Evidence map›Paper›PMID 35662852›Full record

ArticleJAAD case reports2022

A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab.

Renat Ahatov, Allison J Good, Michael Joo, Shelby Tipton, Brandon Goodwin, Brent Kelly

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Cutaneous T-cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. T-cell lymphoma associated with dupilumab.Annals of hematology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Renat AhatovSchool of Medicine, The University of Texas Medical Branch, Galveston, Texas.
Allison J GoodDepartment of Dermatology, The University of Texas Medical Branch, Galveston, Texas.
Michael JooDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas.
Shelby TiptonDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas.
Brandon GoodwinDepartment of Dermatology, The University of Texas Medical Branch, Galveston, Texas.
Brent KellyDepartment of Dermatology, The University of Texas Medical Branch, Galveston, Texas.
The University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CTCL, cutaneous T-cell lymphoma(s)cytotoxic T-cell lymphomadupilumabPCGD-TCL, primary cutaneous γδ T-cell lymphoma(s)primary cutaneous γδ T-cell lymphoma

Identifiers

PMID35662852
PMCPMC9157234
OpenAlexW4229459790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.